CPLM 1.0 - Compendium of Protein Lysine Modification
TagContent
CPLM ID CPLM-024533
UniProt Accession
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
 Inter alpha-trypsin inhibitor, heavy chain 4 
Protein Synonyms/Alias
 ITI heavy chain H4; ITI-HC4; Inter-alpha-inhibitor heavy chain 4 
Gene Name
 Itih4 
Gene Synonyms/Alias
  
Created Date
 July 27, 2013 
Organism
 Mus musculus (Mouse) 
NCBI Taxa ID
 10090 
Lysine Modification
Position
Peptide
Type
References
103KEKAEAQKQYSAAVGubiquitination[1]
224PTLSQQQKSQSEQDTubiquitination[1]
336ATEENLNKAVNYASRubiquitination[1]
607EQFQVAEKPVEVGDGubiquitination[1]
641SKLMTVLKGSRSQIPubiquitination[1]
Reference
 [1] Proteomic analyses reveal divergent ubiquitylation site patterns in murine tissues.
 Wagner SA, Beli P, Weinert BT, Schölz C, Kelstrup CD, Young C, Nielsen ML, Olsen JV, Brakebusch C, Choudhary C.
 Mol Cell Proteomics. 2012 Dec;11(12):1578-85. [PMID: 22790023
Functional Description
 Type II acute-phase protein (APP) involved in inflammatory responses to trauma. May also play a role in liver development or regeneration. 
Sequence Annotation
 DOMAIN 29 148 VIT.
 DOMAIN 274 457 VWFA.
 CARBOHYD 81 81 N-linked (GlcNAc...).
 CARBOHYD 517 517 N-linked (GlcNAc...).
 CARBOHYD 577 577 N-linked (GlcNAc...).
 CARBOHYD 874 874 N-linked (GlcNAc...).
 DISULFID 761 937 By similarity.  
Keyword
 Acute phase; Alternative splicing; Coiled coil; Complete proteome; Disulfide bond; Glycoprotein; Protease inhibitor; Reference proteome; Secreted; Serine protease inhibitor; Signal. 
Sequence Source
 UniProt (SWISSPROT/TrEMBL); GenBank; EMBL 
Protein Length
 942 AA 
Protein Sequence
MKSPAPAHMW NLVLFLPSLL AVLPTTTAEK NGIDIYSLTV DSRVSSRFAH TVVTSRVVNR 60
ADAVQEATFQ VELPRKAFIT NFSMIIDGVT YPGVVKEKAE AQKQYSAAVG RGESAGIVKT 120
TGRQTEKFEV SVNVAPGSKI TFELIYQELL QRRLGMYELL LKVRPQQLVK HLQMDIYIFE 180
PQGISILETE STFMTPELAN ALTTSQNKTK AHIRFKPTLS QQQKSQSEQD TVLNGDFIVR 240
YDVNRSDSGG SIQIEEGYFV HHFAPENLPT MSKNVIFVID KSGSMSGKKI QQTREALVKI 300
LKDLSPQDQF NLIEFSGEAN QWKQSLVQAT EENLNKAVNY ASRIRAHGGT NINNAVLLAV 360
ELLDRSNQAE LLPSKSVSLI ILLTDGDPTV GETNPTIIQN NVREAINGQY SLFCLGFGFD 420
VNYPFLEKMA LDNGGLARRI YEDSDSALQL QDFYHEVANP LLSSVAFEYP SDAVEEVTRY 480
KFQHHFKGSE MVVAGKLQDQ GPDVLLAKVS GQMHMQNITF QTEASVAQQE KEFKSPKYIF 540
HNFMERLWAL LTIQQQLEQR ISASGAELEA LEAQVLNLSL KYNFVTPLTH MVVTKPEGQE 600
QFQVAEKPVE VGDGMQRLPL AAQAHPFRPP VRGSKLMTVL KGSRSQIPRL GDAVRASRQY 660
IPPGFPGPPG PPGFPAPPGP PGFPAPPGPP LASGSDFSLQ PSYERMLSLP SVAAQYPADP 720
HLVVTEKSKE STIPEESPNP DHPQVPTITL PLPGSSVDQL CVDILHSEKP MKLFVDPSQG 780
LEVTGKYENT GFSWLEVTIQ KPHLQVHATP ERLVVTRGRK NTEYKWKKTL FSVLPGLKMT 840
MNMMGLLQLS GPDKVTIGLL SLDDPQRGLM LLLNDTQHFS NNVKGELGQF YRDIVWEPPV 900
EPDNTKRTVK VQGVDYLATR ELKLSYQEGF PGAEISCWTV EI 942 
Gene Ontology
 GO:0005737; C:cytoplasm; IDA:MGI.
 GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
 GO:0005886; C:plasma membrane; IDA:MGI.
 GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
 GO:0006953; P:acute-phase response; IEA:UniProtKB-KW.
 GO:0030212; P:hyaluronan metabolic process; IEA:InterPro. 
Interpro
 IPR010600; ITI_HC_C.
 IPR013694; VIT.
 IPR002035; VWF_A. 
Pfam
 PF06668; ITI_HC_C
 PF08487; VIT
 PF00092; VWA 
SMART
 SM00609; VIT
 SM00327; VWA 
PROSITE
 PS51468; VIT
 PS50234; VWFA 
PRINTS